Quick Answer
COLLEGIUM PHARMACEUTICAL, INC reported Stockholders Equity of $301.68 million for fiscal year 2025.
COLLEGIUM PHARMACEUTICAL, INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $301.68M | +31.8% |
| 2024 | $228.84M | +17.1% |
| 2023 | $195.43M | +0.3% |
| 2022 | $194.84M | -4.0% |
| 2021 | $202.93M | +9.1% |
| 2020 | $186.03M | +112.8% |
| 2019 | $87.43M | -4.5% |
| 2018 | $91.58M | -12.0% |
| 2017 | $104.08M | -22.9% |
| 2016 | $134.91M | +58.6% |
| 2015 | $85.07M | +195.2% |
| 2014 | -$89.35M | -31.0% |
| 2013 | -$68.22M | -11.1% |
| 2012 | -$61.40M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $274.81M | +17.3% | +18.3% |
| June 30, 2025 | $232.21M | +7.2% | -1.0% |
| March 31, 2025 | $234.43M | +5.5% | +2.4% |
| December 31, 2024 | $228.84M | +17.1% | -2.3% |
| September 30, 2024 | $234.28M | +31.0% | +8.2% |
| June 30, 2024 | $216.58M | +7.9% | -2.5% |
| March 31, 2024 | $222.17M | +23.6% | +13.7% |
| December 31, 2023 | $195.43M | +0.3% | +9.3% |
- COLLEGIUM PHARMACEUTICAL, INC showed an increase of +31.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, COLLEGIUM PHARMACEUTICAL, INC’s stockholders equity has grown by 591.3% (from -$61.40 million to $301.68 million).
- The most recent figure is from COLLEGIUM PHARMACEUTICAL, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: